Biotec Pharmacon ASA

Quick facts

Phase 3 pipeline

• SBG · Orthopedics / Rare Genetic Disorders
  SBG is a bone morphogenetic protein (BMP) antagonist that inhibits heterotopic ossification by blocking BMP signaling pathways.
• Soluble beta-glucan (SBG) · Immunology
  Soluble beta-glucan activates innate immune cells to enhance immune response and reduce infection risk.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Biotec Pharmacon ASA portfolio CI brief
• Biotec Pharmacon ASA pipeline updates RSS